Home    Contact    Site Map     

Michael Singer serves as a clinician and researcher at Harvard University.

After an M.D. and Ph.D. at Yale University, he trained clinically at Harvard Medical School. While at Yale, he studied medical informatics with the support of an NIH fellowship. The work led has led to over 30 publications on biomedical pattern analysis, on diverse topics from protein structure to motor vehicle collisions. To build on his interests in medication adherence and preventive medicine, Dr. Singer has invented a number of new medical devices and analysis methods, particularly in the pulmonary space. He is currently a co-leader on a Harvard-funded initiative to use wireless networks to predict and prevent asthma attacks. Dr. Singer serves as a consultant to medical device manufacturers, pharmaceutical companies, and health ministries in other countries. He has carried out considerable work in low-income countries, with an emphasis on Latin America, the Middle East, and the Indian subcontinent. He is a member of the Senior Common Room at Harvard's Eliot House, where he is chairman of the premedical committee.
 

Brian K. Perry, is President and Chief Executive Officer at BKP Technologies, Inc. of Newton, MA. He is responsible for the daily operation and direction of the company and for providing consulting services to clients in the areas of: Application Design/Development; Information Systems Strategies; and Vertical Application implementation. Prior to starting the company in 2001, Mr. Perry was an independent consultant and was the former President and CEO of Versal Technologies, Inc. of Boston, MA where he grew the company from a staff of two to a staff of twelve delivering IT solutions to major pharmaceutical clients around the world. Prior to starting Versal in 1995, Mr. Perry was the Director of Information Systems at Vertex Pharmaceuticals Incorporated of Cambridge, MA. He was also a Systems Engineer with IBM Corporation. Mr. Perry holds a Bachelor of Science in Computer Science, magna cum laude, from Northeastern University.
 

Stuart Woodring’s professional experience over the last 20 years has focused on analyzing the growth and opportunities in technology markets. Throughout his career, he has led high-impact market analyses, managed very talented knowledge workers in a high-growth environment, worked as a member of an executive team to complete a very successful IPO, conducted independent consulting engagements, and participated in venture capital activities.

In 2002, Mr. Woodring completed a successful 12-year career with Forrester Research, one of the leading technology research companies. During his time with Forrester, Mr. Woodring was instrumental in the growth the company's research organization and started numerous new research activities. He served on the company’s executive team, worked to prepare the company for its IPO, managed the entire US research organization, and championed the company’s international expansion. During Mr. Woodring’s employment with Forrester, the company grew from less than 10 employees to over 750. At its peak, Forrester had a market capitalization of over $1 billion.

Prior to joining Forrester Research, Mr. Woodring was an independent marketing and strategy consultant to the computer, communications, and telecommunications industries. His earlier business experience includes corporate finance work with Bank Boston (now part of Bank of America) and management consulting with Bain & Co., a leading strategy consulting firm.

Mr. Woodring is a Phi Beta Kappa graduate of Dartmouth College, with degrees in both engineering sciences and economics. Additionally, Mr. Woodring has participated in executive education programs at Harvard Business School, Columbia Business School, and the Center for Creative Leadership.

© 2006 Clinical Technology Advisors, Inc. All rights reserved.